For example, the selective inhibition of cathepsin K is thought to be beneficial for the treatment of osteoporosis, bone cancers, and certain forms of arthritis, based on the cathepsin K overexpression associated with these diseases [85]. This evidence concerns the gene CTSK and arthritic joint disease.